GLP-1 Weight Loss Trend
Julia Cartwright explores how Ozempic transformed from a diabetes medication into a cultural phenomenon, examining "Ozempic face," stigma, body positivity tensions, and economic ripple effects. She discusses why 12.4% of Americans now use GLP-1s, the ethical questions around supply shortages, and what this $105 billion industry reveals about our relationship with weight, morality, and systemic healthcare challenges. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
4 episodes
Comments
0Be the first to comment
Sign up now and become a member of the GLP-1 Weight Loss Trend community!